
| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| SLP(L) | 192 | 97.5% | -0.84 | 107 | 100.0% |
| LH(L) | 4 | 2.0% | -inf | 0 | 0.0% |
| CentralBrain-unspecified | 1 | 0.5% | -inf | 0 | 0.0% |
| upstream partner | # | NT | conns SLP354 | % In | CV |
|---|---|---|---|---|---|
| CB1178 (L) | 8 | Glu | 38 | 21.1% | 0.9 |
| SLP316 (L) | 1 | Glu | 17 | 9.4% | 0.0 |
| CB1154 (L) | 4 | Glu | 16 | 8.9% | 0.7 |
| CB1838 (L) | 2 | GABA | 11 | 6.1% | 0.8 |
| CB3318 (L) | 2 | ACh | 8 | 4.4% | 0.2 |
| SLP252_b (L) | 1 | Glu | 7 | 3.9% | 0.0 |
| SLP244 (L) | 2 | ACh | 7 | 3.9% | 0.7 |
| SLP341_a (L) | 1 | ACh | 5 | 2.8% | 0.0 |
| CB4138 (L) | 3 | Glu | 5 | 2.8% | 0.6 |
| SLP202 (L) | 1 | Glu | 4 | 2.2% | 0.0 |
| PPL203 (L) | 1 | unc | 4 | 2.2% | 0.0 |
| SMP297 (L) | 2 | GABA | 4 | 2.2% | 0.5 |
| CB3724 (L) | 1 | ACh | 3 | 1.7% | 0.0 |
| LHPV6a3 (L) | 1 | ACh | 3 | 1.7% | 0.0 |
| SLP341_b (L) | 1 | ACh | 3 | 1.7% | 0.0 |
| CB1201 (L) | 2 | ACh | 3 | 1.7% | 0.3 |
| SLP300 (L) | 3 | Glu | 3 | 1.7% | 0.0 |
| CB4088 (L) | 1 | ACh | 2 | 1.1% | 0.0 |
| LHPV6h1_b (L) | 1 | ACh | 2 | 1.1% | 0.0 |
| CB2346 (L) | 1 | Glu | 2 | 1.1% | 0.0 |
| CB4130 (L) | 1 | Glu | 2 | 1.1% | 0.0 |
| CB3556 (L) | 1 | ACh | 2 | 1.1% | 0.0 |
| CB3005 (L) | 1 | Glu | 2 | 1.1% | 0.0 |
| CB3281 (L) | 1 | Glu | 2 | 1.1% | 0.0 |
| SLP355 (R) | 1 | ACh | 2 | 1.1% | 0.0 |
| CB4128 (L) | 1 | unc | 1 | 0.6% | 0.0 |
| SLP011 (L) | 1 | Glu | 1 | 0.6% | 0.0 |
| LHAD1d1 (L) | 1 | ACh | 1 | 0.6% | 0.0 |
| LHAV3g1 (L) | 1 | Glu | 1 | 0.6% | 0.0 |
| SLP385 (L) | 1 | ACh | 1 | 0.6% | 0.0 |
| SLP252_c (L) | 1 | Glu | 1 | 0.6% | 0.0 |
| CB4107 (L) | 1 | ACh | 1 | 0.6% | 0.0 |
| CB4119 (L) | 1 | Glu | 1 | 0.6% | 0.0 |
| CB1281 (L) | 1 | Glu | 1 | 0.6% | 0.0 |
| CB0943 (L) | 1 | ACh | 1 | 0.6% | 0.0 |
| CB1595 (L) | 1 | ACh | 1 | 0.6% | 0.0 |
| SLP344 (L) | 1 | Glu | 1 | 0.6% | 0.0 |
| CB1687 (L) | 1 | Glu | 1 | 0.6% | 0.0 |
| CB1604 (L) | 1 | ACh | 1 | 0.6% | 0.0 |
| CB3109 (L) | 1 | unc | 1 | 0.6% | 0.0 |
| CB1685 (L) | 1 | Glu | 1 | 0.6% | 0.0 |
| SLP347 (L) | 1 | Glu | 1 | 0.6% | 0.0 |
| CB1752 (L) | 1 | ACh | 1 | 0.6% | 0.0 |
| SLP251 (L) | 1 | Glu | 1 | 0.6% | 0.0 |
| SLP208 (L) | 1 | GABA | 1 | 0.6% | 0.0 |
| CSD (L) | 1 | 5-HT | 1 | 0.6% | 0.0 |
| LHPV6a10 (L) | 1 | ACh | 1 | 0.6% | 0.0 |
| SLP457 (L) | 1 | unc | 1 | 0.6% | 0.0 |
| downstream partner | # | NT | conns SLP354 | % Out | CV |
|---|---|---|---|---|---|
| SA3 (L) | 4 | Glu | 75 | 36.9% | 0.5 |
| CB1685 (L) | 2 | Glu | 21 | 10.3% | 0.6 |
| CB1352 (L) | 3 | Glu | 12 | 5.9% | 0.2 |
| SLP149 (L) | 1 | ACh | 7 | 3.4% | 0.0 |
| SA2_b (L) | 2 | Glu | 6 | 3.0% | 0.7 |
| CB4088 (L) | 2 | ACh | 6 | 3.0% | 0.0 |
| SAF (L) | 2 | Glu | 6 | 3.0% | 0.0 |
| CB1178 (L) | 4 | Glu | 6 | 3.0% | 0.3 |
| CB1391 (L) | 3 | Glu | 5 | 2.5% | 0.6 |
| CB4133 (L) | 1 | Glu | 4 | 2.0% | 0.0 |
| CB4138 (L) | 3 | Glu | 4 | 2.0% | 0.4 |
| SLP414 (L) | 1 | Glu | 3 | 1.5% | 0.0 |
| SLP088_b (L) | 1 | Glu | 3 | 1.5% | 0.0 |
| SLP268 (L) | 2 | Glu | 3 | 1.5% | 0.3 |
| CB2346 (L) | 2 | Glu | 3 | 1.5% | 0.3 |
| CB1595 (L) | 2 | ACh | 3 | 1.5% | 0.3 |
| CB4128 (L) | 1 | unc | 2 | 1.0% | 0.0 |
| CB1089 (L) | 1 | ACh | 2 | 1.0% | 0.0 |
| FB9B_a (L) | 1 | Glu | 2 | 1.0% | 0.0 |
| SLP405_a (R) | 1 | ACh | 2 | 1.0% | 0.0 |
| CB3055 (L) | 1 | ACh | 2 | 1.0% | 0.0 |
| SLP344 (L) | 1 | Glu | 2 | 1.0% | 0.0 |
| SLP347 (L) | 1 | Glu | 2 | 1.0% | 0.0 |
| CB3005 (L) | 1 | Glu | 2 | 1.0% | 0.0 |
| CB3281 (L) | 1 | Glu | 2 | 1.0% | 0.0 |
| FB9A (L) | 2 | Glu | 2 | 1.0% | 0.0 |
| SLP252_b (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| CB4087 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| FB9B_b (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| CB1733 (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| SMP167 (L) | 1 | unc | 1 | 0.5% | 0.0 |
| SLP290 (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| LHPD4e1_b (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| CB1838 (L) | 1 | GABA | 1 | 0.5% | 0.0 |
| CB4122 (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| SLP387 (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| CL090_c (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| CB1212 (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| FB7A (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| SLP355 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| LHPV6i2_a (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| LNd_c (L) | 1 | ACh | 1 | 0.5% | 0.0 |